1. Hebra FV: Arztlicher Bericht des K.K allegemeinen Krankenhauses zu Wien vom Jare 1870. Vienna, Pemphigus, 1870, p. 362.
2. Fox T: Notes on unusual or rare forms of skin disease. Lancet 1:766, 1879
3. Goldscheider A: Hereditare Neigung zer Blasenbildung. Monatsschr Prakt Dermatol 1:163, 1882
4. Koebner H: Hereditare Anlage zur Blasenbildung. Dtsch Med Wochenschr 12:21, 1886
5. Hallopeau MH: Nouvelle etude sur la dermatite bulleuse congenitale avec kysts epidermiques. Ann Dermatol Syphiligr (Paris) 7:453, 1896
6. Weber FP: Recurrent bullous eruption on the feet in a child. Proc R Soc Med 19:72, 1926
7. Cockayne EA: Recurrent bullous eruption of feet. Br J Dermatol 50:358, 1938
8. Dowling GB: Epidermolysis bullosa resembling juvenile dermatitis herpetiformis. Br J Dermatol 66:139, 1954
9. Hoffman E: Uber den Erbgang bei Epidermolysis bullosa hereditaria. Arch Rassen Gesellsch Biol 18:353, 1926
10. Cockayne EA: Inherited Abnormalities of the Skin and its Appendages. London, Oxford University Press, 1933
11. Touraine MA: Classification des epidermolyses bulleuses. Ann Dermatol Syphiligr (Paris) 2:141, 1942
12. Pasini A: Dystrophie cutanee bulleuse atrophiante et albopapuloide. Ann Dermatol Syphiligr (Paris) 9:1044, 1928
13. Bart BJ, et al: Congenital localized absence of skin and associated abnormalities resembling epidermolysis bullosa. Arch Dermatol 93:293, 1966
14. Herlitz G: Kongenitaler, nicht syphilitischer Pemphigus: Eine Ubersicht nebst Beschreibung einer neuen Krankheitsform. Acta Paediatr 7:315, 1935
15. Pearson RW: Studies on the pathogenesis of epidermolysis bullosa. J Invest Dermatol 39:551-575, 1962
16. Gedde-Dahl T: Epidermolysis Bullosa: A Clinical, Genetic and Epidemiologic Study. Baltimore, The John Hopkins Press, 1971, pp. 1-180.
17. LeBleu VS, Macdonald B, Kalluri R: Structure and function of basement membranes. Exp Biol Med (Maywood) 232:1121-1129, 2007
18. Yoshida-Moriguchi T et al: O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327:88-92, 2010
19. Arin MJ: The molecular basis of human keratin disorders. Hum Genet 125:355-373, 2009
20. Coulombe PA, Kerns ML, Fuchs E, Epidermolysis bullosa simplex: A paradigm for disorders of tissue fragility. J Clin Invest 119:1784-1793, 2009
21. Rezniczek GA, Janda L, Wiche G: Plectin. Methods Cell Biol 78:721-755, 2004
22. Na S et al: Plectin contributes to mechanical properties of living cells. Am J Physiol Cell Physiol 296:C868-C877, 2009
23. Jefferson JJ et al: Structural analysis of the plakin domain of bullous pemphigoid antigen1 (BPAG1) suggests that plakins are members of the spectrin superfamily. J Mol Biol 366:244-257, 2007
24. Young KG, Kothary R: Dystonin/Bpag1 is a necessary endoplasmic reticulum/nuclear envelope protein in sensory neurons. Exp Cell Res 314:2750-2761, 2008
25. Young KG, Kothary R: Dystonin/Bpag1–A link to what? Cell Motil Cytoskeleton 64:897-905, 2007
26. Leung CL et al: The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 154:691-697, 2001
27. Has C, Kern JS:
Collagen XVII.
Dermatol Clin 28:61-66, 2010
28. Litjens S, de Pereda J, Sonnenberg A: Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol 16:376-383, 2006
29. de Pereda JM, Lillo MP, Sonnenberg A: Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J 28:1180-1190, 2009
30. Dowling J, Yu QC, Fuchs E: Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 134:559-572, 1996
31. Margadant C et al: Regulation of hemidesmosome disassembly by growth factor receptors. Curr Opin Cell Biol 20(5):589-596, 2008
32. Hirako Y et al: Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J Biol Chem 271:13739-13745, 1996
33. Carter WG et al: Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol 111:3141-3154, 1990
34. Zone JJ et al: Identification of the cutaneous basement membrane antigen in linear IgA bullous dermatosis. J Clin Invest 85:812-820, 1990
35. Marinkovich MP et al: LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120- kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 106:734-738, 1996
36. Zone JJ et al: The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 110:207-210, 1998
37. Franzke CW, Bruckner P, Bruckner-Tuderman L: Collagenous transmembrane proteins: Recent insights into biology and pathology. J Biol Chem 280:4005-4008, 2005
38. Franzke CW et al: Shedding of
collagen XVII/BP180: Structural motifs influence cleavage from cell surface.
J Biol Chem 279:24521-24529, 2004
39. Franzke CW et al: Transmembrane
collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs.
Embo J 21:5026-5035, 2002
40. Durbeej M: Laminins. Cell Tissue Res 339:259-268, 2010
41. Miner JH: Laminins and their roles in mammals. Microsc Res Tech 71:349-356, 2008
42. Scheele S et al: Laminin isoforms in development and disease. J Mol Med 85:825-836, 2007
43. Rousselle P et al: Kalinin: An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114: 567-576, 1991
44. Meneguzzi G et al: Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol 1:221-229, 1992
45. Gerecke DR et al: The complete primary structure for a novel laminin chain, the laminin B1k chain. J Biol Chem 269:11073-11080, 1994
46. Ryan MC et al: Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 269:22779-22787, 1994
47. Kallunki P et al: A truncated laminin chain homologous to the B2 chain: Structure, spatial expression, and chromosomal assignment. J Cell Biol 119:679-693, 1992
48. Champliaud MF et al: Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 132:1189-1198, 1996
49. Marinkovich MP et al: The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119:695-703, 1992
50. Marinkovich M, LunstrumG, Burgeson R: The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 267:17900-17906, 1992
51. Giannelli G et al: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277:225-228, 1997
52. Koshikawa N et al: Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148:615-624, 2000
53. Veitch DP et al: Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem 278:15661-15668, 2003
54. Ge G, Greenspan D: Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 78:47-68, 2006
55. Amano S et al: Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J Biol Chem 275:22728-22735, 2000
56. Goldfinger LE et al: The a3 laminin subunit, a6b4 and a3b1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 112:2615-2629, 1999
57. Gagnoux-Palacios L et al: The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol 153:835-850, 2001
58. Fine JD, Horiguchi Y, Couchman JR: 19-DEJ-1, a hemidesmosome-anchoring filament complex associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Arch Dermatol 125:520-523, 1989
59. Parente MG et al: Human type VII
collagen: cDNA cloning and chromosomal mapping of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa.
Am J Hum Genet 24:119-135, 1991
60. Burgeson RE, Lundstrum GP, Rokosova B: The structure and function of type VII
collagen.
Ann N Y Acad Sci 580:32-43, 1990
61. Bachinger HP et al: The relationship of the biophysical and biochemical characteristics of type VII
collagen to the function of anchoring fibrils.
J Biol Chem 265:10095-10101, 1990
62. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N: Biology of anchoring fibrils: Lessons from dystrophic epidermolysis bullosa. Matrix Biol 18:43-54, 1999
63. Gayraud B et al: Characterization of a 50-kDa component of epithelial basement membranes using GDA-J/F3 monoclonal antibody. J Biol Chem 272:9531-9538, 1997
64. Chen M et al: NC1 domain of type VII
collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats.
J Invest Dermatol 112:177-83, 1999
65. Rousselle P et al: Laminin 5 binds the NC-1 domain of type VII
collagen.
J Cell Biol 138:719-28, 1997
66. Nakashima Y et al: Regulation of cell adhesion and type VII
collagen binding by the beta3 chain short arm of laminin-5: effect of its proteolytic cleavage.
J Biochem (Tokyo) 138:539-552, 2005
67. Waterman EA et al: A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res 67:4264-4270, 2007
68. Ortiz-Urda S et al: Type VII
collagen is required for Ras-driven human epidermal tumorigenesis.
Science 307:1773-1776, 2005
69. Chen M et al: The carboxyl terminus of type VII
collagen mediates antiparallel-dimer formation and constitutes a new antigenic epitope for EBA autoantibodies.
J Biol Chem 27:27, 2001
70. Smith LT: Ultrastructural findings in epidermolysis bullosa. Arch Dermatol 129:1578-1584, 1993
71. Fine JD et al: The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931-50, 2008
72. Sprecher E: Epidermolysis bullosa simplex. Dermatol Clin 28:23-32, 2010
73. Morrell D.S et al: Congenital pyloric atresia in a newborn with extensive aplasia cutis congenita and epidermolysis bullosa simplex. Br J Dermatol 143:1342-1343, 2000
74. Shemanko CS et al: Laryngeal involvement in the Dowling-Meara variant of epidermolysis bullosa simplex with keratin mutations of severely disruptive potential. Br J Dermatol 142:315-320, 2000
75. Chavanas S et al: A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest 98:2196-200, 1996
76. Gache Y et al: Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest 97:2289-2298, 1996
77. McLean WH et al: Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 10:1724-1735, 1996
78. Dang M et al: Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Lab Invest 78:195-204, 1998
79. Bauer JW et al: Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol 44:577-84, 2001
80. Fine JD, Johnson L, Wright T: Epidermolysis bullosa simplex superficialis. Arch Dermatol 125:633-638, 1989
81. McGrath JA, Bolling MC,Jonkman MF: Lethal acantholytic epidermolysis bullosa. Dermatol Clin 28:131-135, 2010
82. McGrath J: Hereditary diseases of desmosomes. J Dermatol Sci 20:85-91, 1999
83. Hovnanian A, Duquesnoy P, Amselem S: Genetic linkage of recessive epidermolysis bullosa to the type VII
collagen gene.
J Clin Invest 90:1033-1037, 1992
84. Jonkman MF et al: Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 107:764-769, 1996
85. Coulombe PA: The cellular and molecular biology of keratins: Beginning a new era. Curr Opin Cell Biol 5:17-29, 1993
86. Uttam J et al: The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci USA 93:9079-9084, 1996
87. Irvine AD et al: Molecular confirmation of the unique phenotype of epidermolysis bullosa simplex with mottled pigmentation. Br J Dermatol 144:40-45, 2001
88. Moog U et al: Epidermolysis bullosa simplex with mottled pigmentation: Clinical aspects and confirmation of the P24L mutation in the KRT5 gene in further patients. Am J Med Genet 86:376-379, 1999
89. Chamcheu JC et al: Epidermolysis bullosa simplex due to KRT5 mutations: Mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes. Br J Dermatol 162:980-989, 2010
90. Rezniczek GA, Walko G, Wiche G: Plectin gene defects lead to various forms of epidermolysis bullosa simplex. Dermatol Clin 28:33-41, 2010
91. Konieczny P, Wiche G: Muscular integrity–A matter of interlinking distinct structures via plectin. Adv Exp Med Biol 642:165-175, 2008
92. Natsuga K et al: Plectin deficiency leads to both muscular dystrophy and pyloric atresia in epidermolysis bullosa simplex. Hum Mutat 31(10):E1687-E1698, 2010
93. Groves RW et al: A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 130:1551-1557, 2010
94. McGrath J et al: Skin fragility and hypohidrotic ectodermal dysplasia resulting from ablation of plakophilin 1. Br J Dermatol 140:297-307, 1999
95. Fassihi H et al: Preimplantation genetic diagnosis of skin fragility-ectodermal dysplasia syndrome. Br J Dermatol 154:546-550, 2006
96. Ersoy-Evans S et al: Ectodermal dysplasia-skin fragility syndrome resulting from a new homozygous mutation, 888delC, in the desmosomal protein plakophilin 1. J Am Acad Dermatol 55:157-161, 2006
97. Wessagowit V, McGrath J: Clinical and molecular significance of splice site mutations in the plakophilin 1 gene in patients with ectodermal dysplasia-skin fragility syndrome. Acta Derm Venereol 85:386-388, 2005
98. Hamada T et al: Genotype-phenotype correlation in skin fragility-ectodermal dysplasia syndrome resulting from mutations in plakophilin 1. Exp Dermatol 11:107-114, 2002
99. Whittock N et al: Genomic amplification of the human plakophilin 1 gene and detection of a new mutation in ectodermal dysplasia/skin fragility syndrome. J Invest Dermatol 115:368-374, 2000
100. McGrath J: A novel genodermatosis caused by mutations in plakophilin 1, a structural component of desmosomes. J Dermatol 26:764-769, 1999
101. Fattah A: Epidermolysis bullosa hereditaria letalis (Herlitz). Dermatologica 133:475-481, 1966
102. Laimer M et al: Herlitz junctional epidermolysis bullosa. Dermatol Clin 28:55-60, 2010
103. McLean WH et al: An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Genet 12:2395-2409, 2003
104. Sakai N et al: Observations of skin grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules. J Invest Dermatol 130:2147-2150, 2010.
105. Hintner H, Wolff K: Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 118:375-384, 1982
106. Vidal F et al: Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 10:229-234, 1995
107. Inoue, M et al: A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies Non- Herlitz junctional epidermolysis bullosa without pyloric atresia? J Invest Dermatol 114:1061-1064, 2000
108. Chavanas S et al: Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. Hum Mol Genet 8:2097-2105, 1999
109. Gache Y et al: Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum Mol Genet 10:2453-2461, 2001
110. Pfendner EG et al: Basic science of epidermolysis bullosa and diagnostic and molecular characterization: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol 46:781-794, 2007
111. Varki R et al: Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants. J Med Genet 43:641-652, 2006
112. Kivirikko S et al: Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. Hum Mol Genet 5:231-237, 1996
113. McGrath JA et al: Altered laminin 5 expression due to mutations in the gene encoding the B3 chain in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 104:467-474, 1995
114. Cserhalmi-Friedman PB et al: Molecular basis of non-lethal junctional epidermolysis bullosa: Identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene. Exp Dermatol 7:105-111, 1998
115. Pulkkinen L et al: LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: Consequences at the mRNA and protein levels. Lab Invest 78:859-867, 1998
116. Vaisanen L et al: Molecular mechanisms of junctional epidermolysis bullosa: Col 15 domain mutations decrease the thermal stability of
collagen XVII.
J Invest Dermatol 125:1112-1118, 2005
117. Fontao L et al: Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex. J Invest Dermatol 122:65-72, 2004
118. Floeth M et al: Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa. J Invest Dermatol 111:528-533, 1998
119. Jonkman MF et al: Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88:543-551, 1997
120. Pasmooij A et al: Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet 77:727-40, 2005
121. Hashimoto K, Matsumoto M, Iacobelli D: Transient bullous dermolysis of the newborn. Arch Dermatol 121:1429-1438, 1985
122. Smith LT, Sybert VP: Intra-epidermal retention of type VII
collagen in a patient with recessive dystrophic epidermolysis bullosa.
J Invest Dermatol 94:261, 1990
123. Cui Y et al: Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. Genes Dev 9:423-436, 1995
124. Uitto J, Pulkkinen L, Christiano AM: Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: Mutations in the type VII
collagen and kalinin (laminin 5) genes.
J Invest Dermatol 103:39S-46S, 1994
125. Christiano AM et al: Premature termination codons in the type VII
collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
Genomics 21:160-168, 1994
126. Almaani N et al: Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 130:1937-1940, 2010
127. Mellerio JE et al: Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol 112:984-987, 1999
128. Bruckner-Tuderman L et al: Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to
collagen VII through removal of the NC-2 domain.
J Cell Biol 131:551-559, 1995
129. Kindler T: Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol 66:104-111, 1954
130. Ashton G: Kindler syndrome. Clin Exp Dermatol 29:116-121, 2004
131. Patrizi A et al: Kindler syndrome: Report of a case with ultrastructural study and review of the literature. Pediatr Dermatol 13:397-402, 1996
132. Haber R, Hanna W: Kindler syndrome. Clinical and ultrastructural findings. Arch Dermatol 132:1487-1490, 1996
133. Forman A et al: Kindler syndrome: Report of two cases and review of the literature. Pediatr Dermatol 6:91-101, 1989
134. Hovnanian A, Blanchet-Bardon C, de Prost Y: Poikiloderma of Theresa Kindler: Report of a case with ultrastructural study, and review of the literature. Pediatr Dermatol 6:82-90, 1989
135. Hacham-Zadeh S, Garfunkel A: Kindler syndrome in two related Kurdish families. Am J Med Genet 20:43-48, 1985
136. Verret J et al: [Kindler syndrome. Case report with ultrastructure study]. [Article in French.] Ann Dermatol Venereol 111:259-269, 1984
137. Lai-Cheong JE et al: Kindler syndrome: A focal adhesion genodermatosis. Br J Dermatol 160:233-242, 2009
138. Has C et al: Molecular basis of Kindler syndrome in Italy: Novel and recurrent Alu/Alu recombination, splice site, nonsense, and frameshift mutations in the KIND1 gene. J Invest Dermatol 126:1776-1783, 2006
139. Lanschuetzer C et al: Gene symbol: Kind1. Disease: Kindler syndrome. Hum Genet 115:175, 2004
140. Ashton G et al: Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol 122:78-83, 2004
141. Fassihi H et al: Prenatal diagnosis for severe inherited skin disorders: 25 years' experience. Br J Dermatol 154:106-113, 2006
142. Marinkovich MP et al: Prenatal diagnosis of Herlitz junctional epidermolysis bullosa by amniocentesis. Prenat Diagn 15:1027-1034, 1995
143. McGrath JA et al: First trimester DNA-based exclusion of recessive dystrophic epidermolysis bullosa from chorionic villus sampling. Br J Dermatol 134:734-739, 1996
144. Cserhalmi-Friedman PB et al: Preimplantation genetic diagnosis in two families at risk for recurrence of Herlitz junctional epidermolysis bullosa. Exp Dermatol 9:290-297, 2000
145. Kaiser J: Prenatal diagnosis. An earlier look at baby's genes. Science 309:1476-1478, 2005
146. Lin AN, Carter DM, eds. Epidermolysis Bullosa: Basic and Clinical Aspects. New York, Springer-Verlag, 1992, p. 302.
147. Terrill PJ et al: The surgical management of dystrophic epidermolysis bullosa (excluding the hand). Br J Plast Surg 45:426-434, 1992
148. Terrill PJ, Mayou BJ, Pemberton J: Experience in the surgical management of the hand in dystrophic epidermolysis bullosa. Br J Plast Surg 45:435-442, 1992
149. Ladd AL, Kibele A, Gibbons S: Surgical treatment and postoperative splinting of recessive dystrophic epidermolysis bullosa. J Hand Surg Am 21:888-897, 1996
150. Greider JL, Flatt AE: Surgical restoration of the hand in epidermolysis bullosa. Arch Dermatol 124:765-767, 1988
151. Glicenstein J, Mariani D, Haddad R: The hand in recessive dystrophic epidermolysis bullosa. Hand Clin 16:637-45, 2000
152. Falabella AF et al: Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 136:1225-1230, 2000
153. Bastin KT, Steeves RA, Richards MJ: Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: Case reports and literature review. Am J Clin Oncol 20:55-58, 1997
154. Fine JD et al: Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: Results of a phase 1 trial of systemic
isotretinoin.
J Am Acad Dermatol 50:563-571, 2004
155. Arnold AW et al:
Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Dermatology 219(1):80-83, 2009
156. Ergun GA et al: Gastrointestinal manifestations of epidermolysis bullosa. A study of 101 patients. Medicine 71:121-127, 1992
157. Haynes L et al: Gastrostomy and growth in dystrophic epidermolysis bullosa. Br J Dermatol 134:872-879, 1996
158. McDonnell PJ, Schofield OMV, Spalton DJ: Eye involvement in junctional epidermolysis bullosa. Arch Opthalmol 107:1635-1637, 1989
159. Gans LA: Eye lesions of epidermolysis bullosa. Arch Dermatol 124:762-764, 1988
160. Kirkham J et al: The chemical composition of tooth enamel in junctional epidermolysis bullosa. Arch Oral Biol 45:377-386, 2000
161. Serrano Martinez C et al: Hereditary epidermolysis bullosa. Dental management of three cases. Med Oral 6:48-56, 2001
162. Travis SP et al: Oral and gastrointestinal manifestations of epidermolysis bullosa. Lancet 340:1505-1506, 1992
163. Tesi D, Lin AN: Nutritional management of the epidermolysis bullosa patient. In: Epidermolysis Bullosa – Basic and Clinical Aspects, edited by AN Lin, DM Carter. New York, Springer-Verlag, 1992, Chapter 21.
164. Lara-Corrales I, Pope E: Dilated cardiomyopathy in epidermolysis bullosa. Dermatol Clin 28(2):347-351, 2010
165. Fridge JL, Vichinsky EP: Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr. 132:871-873, 1998
166. Ingen-Housz-Oro S et al: Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol 18(6):649-653, 2004
167. Martinez AE, Mellerio JE: Osteopenia and osteoporosis in epidermolysis bullosa. Dermatol Clin 28(2):353-355, 2010
168. Dietz M: A day in the life of a patient with DDEB. J Am Acad Dermatol 51:S58-S59, 2004
169. Goldschneider KR, Lucky AW: Pain management in epidermolysis bullosa. Dermatol Clin 28:273-282, ix, 2010
170. Tabolli S et al: Quality of life in patients with epidermolysis bullosa. Br J Dermatol 161:869-877, 2009
171. Schomer H, Vergunst R: Psychological factors in epidermolysis bullosa. S Afr Med J 81:580, 1992
172. Moss K: Contact at the borderline: Psychoanalytic psychotherapy with EB patients. Br J Nurs 17:449-455, 2008
173. Lansdown R et al: Practical and psychological problems for parents of children with epidermolysis bullosa. Child Care Health Dev 12:251-256, 1986
174. Veien NK, Buus SK: Treatment of epidermolysis bullosa simplex (EBS) with
tetracycline.
Arch Dermatol 136:424-425, 2000
175. Rothnagel JA et al: Transgenic models of skin diseases. Arch Dermatol 129:1430-1436, 1993
176. Cao T et al: An inducible mouse model for epidermolysis bullosa simplex: Implications for gene therapy. J Cell Biol 152:651-656, 2001
177. Bruckner-Tuderman L et al: Animal models of epidermolysis bullosa: Update 2010. J Invest Dermatol 130:1485-1488, 2010
178. Bubier JA et al: A mouse model of generalized non-Herlitz junctional epidermolysis bullosa. J Invest Dermatol 130:1819-1828, 2010
179. Meng X et al: Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa. J Invest Dermatol 121:720-731, 2003
180. Natsuga K et al: Animal models of epidermolysis bullosa. Dermatol Clin 28:137-142, 2010
181. Heinonen S et al: Targeted inactivation of the type VII
collagen gene (Col7a1) in mice results in severe blistering phenotype: A model for recessive dystrophic epidermolysis bullosa.
J Cell Sci 112:3641-3648, 1999
182. Kim YH et al: Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: Development of an experimental in vivo model. J Invest Dermatol 98:191-197, 1992
183. Woodley DT et al: Injection of recombinant human type VII
collagen restores
collagen function in dystrophic epidermolysis bullosa.
Nat Med 10:693-695, 2004
184. Ferrari S et al: Gene therapy approaches for epidermolysis bullosa. Clin Dermatol 23:430-436, 2005
185. Titeux M, Pendaries V, Hovnanian A: Gene therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28:361-366, xii, 2010
186. Seitz CS et al: BP180 gene delivery in junctional epidermolysis bullosa. Gene Ther 6:42-47, 1999
187. Robbins PB et al: In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 98:5193-5198, 2001
188. Ortiz-Urda S et al: Stable nonviral genetic correction of inherited human skin disease. Nat Med 8:1166-1170, 2002
189. Ortiz-Urda S et al: Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 111:251-255, 2003
190. Woodley DT et al: Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. Mol Ther 10:318-326, 2004
191. Baldeschi C et al: Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 12:1897-1905, 2003
192. Mavilio F et al: Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-402, 2006
193. Marinkovich MP et al: Cellular origin of the dermal-epidermal basement membrane. Dev Dyn 197:255-267, 1993
194. Woodley DT et al: Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII
collagen at the basement membrane zone.
J Invest Dermatol 121:1021-1028, 2003
195. Remington J et al: Injection of recombinant human type VII
collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
Mol Ther 17:26-33, 2009
196. Wong T et al: Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179-2189, 2008
197. Yan WF, Murrell DF: Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 28:367-370, xii, 2010
198. Kiuru, M et al: Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin28:371-382, xii-xiii, 2010
199. Tolar J et al: Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113:1167-1174, 2009
200. Tamai K, Kaneda Y, Uitto J: Molecular therapies for heritable blistering diseases. Trends Mol Med 15:285-292, 2009
201. Wagner JE et al: Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363(7):629-639, 2010